APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,641,000 | -20.6% | 32,298 | -26.1% | 0.00% | 0.0% |
| Q4 2021 | $2,068,000 | +25.8% | 43,733 | -12.3% | 0.00% | 0.0% |
| Q3 2021 | $1,644,000 | -55.0% | 49,890 | -13.6% | 0.00% | -50.0% |
| Q2 2021 | $3,650,000 | +175.5% | 57,748 | +86.9% | 0.00% | +100.0% |
| Q1 2021 | $1,325,000 | -56.1% | 30,890 | -41.5% | 0.00% | -50.0% |
| Q4 2020 | $3,020,000 | +363.2% | 52,793 | +144.1% | 0.00% | – |
| Q3 2020 | $652,000 | -35.2% | 21,626 | -29.8% | 0.00% | -100.0% |
| Q2 2020 | $1,006,000 | +276.8% | 30,804 | +209.6% | 0.00% | – |
| Q1 2020 | $267,000 | -8.6% | 9,950 | +4.3% | 0.00% | – |
| Q4 2019 | $292,000 | +17.7% | 9,541 | -7.4% | 0.00% | – |
| Q3 2019 | $248,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,160,000 | $163,403,600 | 25.44% |
| Avoro Capital Advisors LLC | 10,625,000 | $549,418,750 | 8.21% |
| Logos Global Management LP | 1,350,000 | $69,808,500 | 8.18% |
| EcoR1 Capital, LLC | 5,183,431 | $268,035,217 | 8.16% |
| Saturn V Capital Management LP | 212,329 | $9,414,319 | 7.81% |
| ACUTA CAPITAL PARTNERS, LLC | 217,500 | $11,246,925 | 6.92% |
| Ghost Tree Capital, LLC | 300,000 | $15,513,000 | 6.62% |
| Finepoint Capital LP | 334,890 | $17,317 | 5.60% |
| Cormorant Asset Management, LP | 1,576,872 | $81,540 | 5.46% |
| Tri Locum Partners LP | 221,897 | $11,474,000 | 4.64% |